First Online: 2 December 2014
: R.I.G.H. has acted as an advisory board member and speaker for Novo Nordisk, and as a speaker for Boehringer Ingelheim, Bristol–Myers Squibb, Eli Lilly, Janssen, Lundbeck, Merck Sharpe and Dohme, Otsuka and Sanofi–Aventis. He has received grants in support of investigator trials from Novo Nordisk. A.J.M. declares no competing interests.